Cargando…
Quality of reporting in oncology phase II trials: A 5-year assessment through systematic review
BACKGROUND: Phase II clinical trials are a cornerstone of the development in experimental treatments They work as a "filter" for phase III trials confirmation. Surprisingly the attrition ratio in Phase III trials in oncology is significantly higher than in any other medical specialty. This...
Autores principales: | Langrand-Escure, Julien, Rivoirard, Romain, Oriol, Mathieu, Tinquaut, Fabien, Rancoule, Chloé, Chauvin, Frank, Magné, Nicolas, Bourmaud, Aurélie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720777/ https://www.ncbi.nlm.nih.gov/pubmed/29216190 http://dx.doi.org/10.1371/journal.pone.0185536 |
Ejemplares similares
-
Outcomes Definitions and Statistical Tests in Oncology Studies: A Systematic Review of the Reporting Consistency
por: Rivoirard, Romain, et al.
Publicado: (2016) -
Social inequalities and cancer: can the European deprivation index predict patients' difficulties in health care access? a pilot study
por: Moriceau, Guillaume, et al.
Publicado: (2015) -
Cancer patients treated with intravenous chemotherapy for the first time. What are their needs? What do they lack? A qualitative–quantitative mixed approach
por: Garcia, Max-Adrien, et al.
Publicado: (2018) -
Radiotherapy among nonagenarians with anal or rectal carcinoma: should we avoid or adapt treatment?
por: Vallard, Alexis, et al.
Publicado: (2017) -
Decision aid on breast cancer screening reduces attendance rate: results of a large-scale, randomized, controlled study by the DECIDEO group
por: Bourmaud, Aurelie, et al.
Publicado: (2016)